Creating the World's
Most Durable Heart Valve
Through Better Science & Better Design

ADAPT® is proven not to calcify over 10 years

Better Hemodynamics & Better Leaflet Performance

The Right...
Opportunity
Time
Technology

To those who say “we must accept limitations” we say:
Bring it onWe are relentless in our pursuit of excellence because patients need durable solutions now.

Latest News
Eureka Report - How Anteris Technologies got its credibility back
CEO Wayne Paterson (Anteris Technologies) is interviewed by Alan Kohler, Editor-in-Chief at Eureka Report
Q&A with StockPal - Anteris Technologies (ASX:AVR)
CEO W. Paterson interviewed by J. Sim, Editor-in-Chief & Co-Founder at StockPal.
Bioshares - Anteris Demonstrates ADAPT Process Outperforms Medtronic's AOA Process in Animal Study
Bioshares - Anteris Demonstrates ADAPT Process Outperforms Medtronic's AOA Process in Animal Study
Anteris Technologies (ASX:AVR) interview with Proactive Investors
Anteris Technologies Ltd's (ASX:AVR) (OTCMKTS:AMEUF) (FRA:DDF) Wayne Paterson tells Proactive's Andrew Scott its share price has moved up to reflect the progress of the last two years.
ASX Small Mid Conference - Anteris Technologies
Anteris Technologies ASX SMID Conference on demand video
FNN Online Investor Event
Anteris Technologies (ASX:AVR) Presentation FNN Online Investor Event
Notice of Extraordinary General Meeting
To be held 19th March 2021
MST Access - Q4 Results: Fresh Funds Available
Trials progressing well
CEO Wayne Paterson is interviewed by 180 Markets
CEO Wayne Paterson interview with 180 Markets
Anteris Technologies (ASX:AVR) nabs $20M funding package
CEO W. Paterson discusses the new funding package and upcoming FDA activities
Anteris set the stage in 2020 to prepare for DurAVR™ THV to be implanted in humans in 2021
""
Anteris presenting at the Switzer Small & Micro-Cap Conference
CEO Wayne Paterson provided a company overview and discussed the strategic direction of Anteris, followed by a brief Q&A session with investors. The event was hosted by Peter Switzer and attendees had the opportunity to hear from ASX-listed small & micro-cap companies across a range of different sectors.